Those aiming for above-average market returns often engage in the meticulous process of stock picking. Choosing the right stocks can make a substantial difference in your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
After finishing at $2.26 in the prior trading day, Taysha Gene Therapies Inc (NASDAQ: TSHA) closed at $2.14, down -5.31%. In other words, the price has decreased by -$5.31 from its previous closing price. On the day, 1.55 million shares were traded. TSHA stock price reached its highest trading level at $2.2762 during the session, while it also had its lowest trading level at $2.12.
Ratios:
Our goal is to gain a better understanding of TSHA by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 3.36 and its Current Ratio is at 3.36. In the meantime, Its Debt-to-Equity ratio is 1.13 whereas as Long-Term Debt/Eq ratio is at 1.10.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, BMO Capital Markets on June 27, 2024, initiated with a Outperform rating and assigned the stock a target price of $5.
On April 09, 2024, Piper Sandler started tracking the stock assigning a Overweight rating and target price of $9.
Jefferies Downgraded its Buy to Hold on February 01, 2023, whereas the target price for the stock was revised from $14 to $1.50.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jun 27 ’24 when Manning Paul B bought 1,333,333 shares for $2.25 per share. The transaction valued at 2,999,999 led to the insider holds 1,333,333 shares of the business.
Manning Paul B bought 100,000 shares of TSHA for $163,000 on Nov 17 ’23. The 10% Owner now owns 16,566,667 shares after completing the transaction at $1.63 per share. On Aug 24 ’23, another insider, Alam Kamran, who serves as the Chief Financial Officer of the company, sold 33,000 shares for $2.33 each. As a result, the insider received 76,890 and left with 258,042 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, TSHA now has a Market Capitalization of 430951104 and an Enterprise Value of 337622112. For the stock, the TTM Price-to-Sale (P/S) ratio is 30.43 while its Price-to-Book (P/B) ratio in mrq is 7.43. Its current Enterprise Value per Revenue stands at 23.85 whereas that against EBITDA is -4.341.
Stock Price History:
Over the past 52 weeks, TSHA has reached a high of $4.32, while it has fallen to a 52-week low of $0.62. The 50-Day Moving Average of the stock is -26.17%, while the 200-Day Moving Average is calculated to be -8.08%.
Shares Statistics:
The stock has traded on average 2.70M shares per day over the past 3-months and 1788955 shares per day over the last 10 days, according to various share statistics. A total of 186.96M shares are outstanding, with a floating share count of 154.92M. Insiders hold about 23.07% of the company’s shares, while institutions hold 65.08% stake in the company. Shares short for TSHA as of 1719532800 were 13450773 with a Short Ratio of 4.99, compared to 1717113600 on 16121850. Therefore, it implies a Short% of Shares Outstanding of 13450773 and a Short% of Float of 8.8599995.
